Examination of the Pancreas in New-onset Diabetes

Overview

About this study

The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Study closed to enrollment

Patient Characteristics:

  • Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values
    • HbA1C ≥ 6.5%
  • No acute illness or steroid therapy
  • No prior pancreas surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Gloria Petersen, Ph.D.

Closed for enrollment

Contact information:

Jennifer Brooks

(507) 266-5156

Brooks.Jennifer@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20123050

Mayo Clinic Footer